Clinical trial
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
NCT00607425 is registered in ClinicalTrials.gov with Scottsdale Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
- Lead sponsor
- Scottsdale Healthcare
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 31, 2007
- Completion date
- July 31, 2008
- Enrollment
- 40 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer